ezogabine has been researched along with perampanel in 4 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (perampanel) | Trials (perampanel) | Recent Studies (post-2010) (perampanel) |
---|---|---|---|---|---|
383 | 26 | 241 | 520 | 75 | 508 |
Protein | Taxonomy | ezogabine (IC50) | perampanel (IC50) |
---|---|---|---|
Glutamate receptor 1 | Homo sapiens (human) | 1.8082 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burke, RA; Faulkner, MA | 1 |
Citraro, R; Coppola, A; De Sarro, G; Del Gaudio, L; Palleria, C; Russo, E; Striano, S | 1 |
Brodie, MJ | 1 |
Gedzelman, ER; Karakis, I; Mauricio, EA; Rudzinski, LA; Shih, JJ; VĂ©lez-Ruiz, NJ | 1 |
4 review(s) available for ezogabine and perampanel
Article | Year |
---|---|
Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.
Topics: Anticonvulsants; Carbamates; Drug Monitoring; Drug Resistance; Epilepsy, Complex Partial; Humans; Nitriles; Patient Selection; Phenylenediamines; Potassium Channels, Voltage-Gated; Pyridones; Receptors, AMPA | 2013 |
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.
Topics: Acetamides; Anticonvulsants; Carbamates; Clinical Trials as Topic; Dibenzazepines; Epilepsy, Temporal Lobe; Hippocampus; Humans; Lacosamide; Levetiracetam; Nitriles; Phenylenediamines; Piracetam; Pyridones; Sclerosis; Syndrome | 2015 |
Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.
Topics: Acetamides; Adult; Aged; Animals; Anticonvulsants; Carbamates; Dibenzazepines; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Lacosamide; Male; Middle Aged; Nitriles; Phenylenediamines; Pyridones | 2015 |
New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.
Topics: Anticonvulsants; Benzodiazepines; Carbamates; Clobazam; Humans; Nitriles; Phenylenediamines; Pyridones; Treatment Outcome | 2016 |